Related by context. All words. (Click for frequent words.) 63 thrombolytic therapy 62 posttransplant 62 ipsilateral stroke 61 reperfusion therapy 60 seroconversion 60 COPD exacerbation 60 adenotonsillectomy 60 virological response 60 recurrent VTE 59 postoperatively 59 hours postdose 59 alteplase 59 antibiotic prophylaxis 59 biochemical relapse 59 intravenous tPA 59 acute STEMI 59 virologic failure 59 interquartile range 58 recurrent wheezing 58 asthma exacerbation 58 chemoprophylaxis 58 CMV infection 58 NIHSS score 58 tPA 58 systemic corticosteroids 58 reperfusion 57 HSCT 57 thrombolysis 57 extubation 57 antibiotic therapy 57 timepoints 57 colectomy 57 amoxicillin clavulanate 56 progression TTP 56 recurrent atrial fibrillation 56 APTIVUS r 56 Median survival 56 fibrinolytic therapy 56 URTI 56 clot busting therapy 56 aminotransferase elevations greater 56 postvaccination 56 mg QD 56 seroprotection 56 postop 56 virological failure 56 electrical cardioversion 56 asthma exacerbations 56 CMV disease 56 EDSS score 56 PSADT 56 laxation 56 extubated 56 asymptomatic 56 bronchodilation 56 postexposure prophylaxis 56 febrile illness 56 seropositivity 56 IELT 56 dyspnea 56 aged ≥ 56 evaluable subjects 56 bacteremia 56 hepatitis C genotype 55 octreotide LAR 55 severe neutropenia 55 HbA 1c levels 55 perioperatively 55 EDSS scores 55 detectable HCV RNA 55 HbA1c levels 55 hyperbilirubinemia 55 intravenous vancomycin 55 oral prednisone 55 creatinine clearance 55 postdischarge 55 ALT flares 55 NATRECOR R 55 disease progression 55 postoperative complications 55 thrombocytopenic 55 renal dysfunction 55 Influenza vaccination 55 definite stent thrombosis 55 reinfarction 55 antibody titer 55 prodromal symptoms 55 lipid lowering therapy 55 tamoxifen therapy 55 fibrinolysis 55 μmol L 55 MADRS score 55 % CI #.#-#.# [003] 55 QRS duration 54 rizatriptan 54 CCyR 54 Tmax 54 febrile seizure 54 NNT = 54 candidemia 54 thromboprophylaxis 54 noncardiac surgery 54 mg/m2 dose 54 RLS symptoms 54 microalbuminuria 54 endophthalmitis 54 % CI #.#-#.# [007] 54 BYSTOLIC 54 solifenacin 54 mL kg 54 HBeAg seroconversion 54 REYATAZ r arm 54 HAART 54 methotrexate monotherapy 54 mg/m2/day 54 virologic response 54 prodrome 54 bolus dose 54 sustained virologic response 54 cART 54 upper gastrointestinal bleeding 54 complete cytogenetic response 54 #mg/day [002] 54 HIV HCV coinfected 54 neurologic sequelae 54 P = .# 54 mg kg dose 54 prior chemotherapy regimens 54 post operatively 54 CK MB 54 thrombotic complications 54 SCr 54 viremia 54 sUA 54 QTcF 54 androgen deprivation 54 gout flares 54 recurrent genital herpes 54 concomitant medications 54 montelukast 54 neurologic complications 54 alanine aminotransferase ALT 54 HBeAg positive patients 54 recurrent venous thromboembolism 54 RRMS patients 53 postprocedure 53 biologic DMARD 53 biochemical recurrence 53 GH deficiency 53 rtPA 53 CR nPR 53 #mg dose [001] 53 insulin detemir 53 flutamide 53 NSTEMI 53 androgen suppression 53 Hb A1C 53 subclinical hypothyroidism 53 transaminase elevations 53 prophylaxis 53 NNRTI resistance 53 GnRH agonist 53 aneurysm rupture 53 SLNB 53 Kaplan Meier analysis 53 OGTT 53 unprotected intercourse 53 hour bronchodilation 53 Cmax 53 serum sodium 53 empyema 53 concomitant antibiotics 53 severe exacerbations 53 nonobstructive CAD 53 Kaplan Meier estimate 53 beta blocker therapy 53 OAB symptoms 53 tuberculin skin testing 53 clopidogrel pretreatment 53 antihypertensive therapy 53 preintervention 53 A1c levels 53 STEMI patients 53 ≥ 53 ischemic stroke 53 tumor resection 53 MMSE scores 53 oral prednisolone 53 perioperative complications 53 #mg dose [002] 53 tirofiban 53 palivizumab 53 febrile seizures 53 adenomatous polyps 53 timepoint 53 hypokalemia 53 antiviral therapy 53 prophylactic antibiotics 53 antibody titers 53 potent antiretroviral therapy 53 dexamethasone 53 adalimumab 53 coronary angiography 53 postoperative 53 invasive fungal infection 53 infliximab 53 periprocedural 53 antiretroviral naive 53 rFVIIa 53 serum aminotransferase levels 53 COPD exacerbations 53 alanine aminotransferase 53 aspirin therapy 53 stent implantation 53 baseline HbA1c 53 postintervention 53 serum concentrations 53 inhospital 53 GERD symptoms 53 cerebral vasospasm 53 IQR 53 certolizumab 53 susceptible isolates 53 cerebrovascular accidents 53 systolic dysfunction 53 β blockers 53 divalproex sodium 53 bacteraemia 53 median PFS 52 plasma glucose 52 4mg/kg 52 HCV infected 52 antihypertensive medication 52 etanercept 52 plasma cortisol 52 rehospitalization 52 dose titration 52 DAS# [002] 52 breastfed infants 52 LTBI 52 HBeAg negative 52 hepatectomy 52 Postoperative complications 52 MACCE 52 cefazolin 52 advanced adenoma 52 subtrochanteric 52 T1DM 52 overt nephropathy 52 tiotropium 52 chlorambucil 52 monoamine oxidase inhibitors MAOIs 52 urinary albumin excretion 52 underwent resection 52 relapsed AML 52 ribavirin therapy 52 advanced neoplasia 52 nondiabetic patients 52 comorbid conditions 52 LV dysfunction 52 ethambutol 52 mcg dose 52 antimicrobial prophylaxis 52 paroxysmal AF 52 warfarin therapy 52 peginterferon 52 Hypotension 52 varicella vaccines 52 systemic corticosteroid 52 preterm deliveries 52 PRADAXA #mg 52 achieved ACR# 52 sinus rhythm 52 ropinirole 52 febrile neutropenia 52 pulmonary exacerbation 52 fragility fracture 52 cirrhotic patients 52 postoperative mortality 52 adjuvant chemotherapy 52 immunocompetent 52 #mg/day [001] 52 hematologic toxicity 52 ug kg 52 plasma concentrations 52 revascularization procedures 52 chronic rhinosinusitis 52 left ventricular dysfunction 52 DAPT 52 RECIST criteria 52 undetectable viral load 52 tissue plasminogen activator tPA 52 ICD implantation 52 luteal phase 52 levetiracetam 52 glycated hemoglobin levels 52 intensive statin therapy 52 EBRT 52 underwent liver transplantation 52 reflux symptoms 52 pulmonary artery banding 52 monoinfected patients 52 relapsed MM 52 activator tPA 52 neutrophil counts 52 intraocular inflammation 52 HAART regimen 52 serum creatinine levels 52 triamcinolone 52 PSA nadir 52 antiplatelet medication 52 LMWH 52 platelet reactivity 52 DHCA 52 weekly subcutaneous injections 52 pneumococcal vaccination 52 VT VF 52 ertapenem 52 virologic responses 52 RSV hospitalizations 52 anagrelide 52 ALT elevation 52 liver transplant recipients 52 intramuscularly 52 atazanavir ritonavir 52 asystole 52 AVODART 52 μg dL 52 aPTT 52 unfractionated heparin 52 Lamictal XR 52 hypomagnesemia 52 undetectable HCV RNA 52 pramipexole 52 intravenous tissue plasminogen 52 log# reduction 52 NATRECOR ® 51 generalized seizures 51 afebrile 51 rapid virologic response 51 FEV1 51 pneumococcal infection 51 Febrile neutropenia 51 RLS sufferers 51 severe rotavirus gastroenteritis 51 postdose 51 curative resection 51 clot busting drug 51 NIHSS 51 Chronic cough 51 plus methotrexate 51 adjunctive placebo 51 Norovirus infection 51 dual antiplatelet therapy 51 aldosterone antagonists 51 lymphocyte count 51 hypophosphatemia 51 tamsulosin 51 refractory ischemia 51 VUR 51 peginterferon alfa 2a 51 levodopa therapy 51 intermittent dosing 51 HAART initiation 51 REYATAZ 51 QT intervals 51 plasma glucose levels 51 EXJADE 51 neonates 51 platelet inhibition 51 neurodevelopmental impairment 51 null responders 51 Subarachnoid hemorrhage 51 acute aortic dissection 51 glucose tolerance test 51 rapid virological response 51 anticoagulation 51 serum testosterone 51 clot dissolving drug 51 radiographic progression 51 cerebrovascular accident 51 symptoms 51 ORENCIA 51 CrCl 51 genital herpes infections 51 antithymocyte globulin 51 incubation period 51 μg dose 51 hepatorenal syndrome 51 VZV 51 primary aldosteronism 51 generalized tonic clonic seizures 51 intravenous bolus 51 viral suppression 51 #mg BID [001] 51 Venous thromboembolism 51 BARACLUDE ® 51 Crohn Disease Activity 51 doxazosin 51 #mg QD [002] 51 acute otitis media 51 GIK infusion 51 LAB GHRH 51 nifedipine 51 nonfatal myocardial infarction 51 #mg/m# [002] 51 serum HCV RNA 51 tolterodine 51 titers 51 virologic breakthrough 51 urinary symptoms 51 posttreatment 51 isoniazid 51 neoadjuvant chemotherapy 51 cilostazol 51 nonpregnant women 51 creatinine ratio 51 desvenlafaxine succinate 51 MYLOTARG 51 ng mL 51 MULTAQ 51 enteroviral infection 51 mitomycin C 51 tolterodine ER 51 acute gout flares 51 poor metabolizers 51 dexmedetomidine 51 mg dose 51 pretest probability 51 histologically confirmed 51 mcg kg 51 intradermal injections 51 mg d 51 neurologic symptoms 51 sd = 51 DMARD 51 breastfed exclusively 51 statin therapy 51 HBV infections 51 elevated ALT 51 milrinone 51 adjuvant tamoxifen 51 g dL 51 mcg mL 51 Hemopurifier ® treatments 51 BCG vaccinated 51 antidepressant therapy 51 hemoglobin concentrations 51 chest radiography 51 antihypertensive medications 51 % CI #.#-#.# [006] 51 Virologic failure 51 seroconverted 51 estimated glomerular filtration 51 intravenous diuretics 51 cTnT 51 typical antipsychotics 51 histrelin 51 confidence interval CI 51 DMARD therapy 51 intravitreal injections 51 MCV4 51 acute ischemic stroke 51 reintubation 51 autistic regression 51 thromboembolic events 51 disease progression TTP 51 advanced adenomas 51 inhaled nitric oxide 51 pneumonectomy 51 pCR 51 thromboses 51 hemorrhagic complications 51 comorbidities 51 intravenous IV infusion 51 hyperglycemia 51 quetiapine 51 antiretroviral regimens 51 Apgar scores 51 proliferative retinopathy 51 undetectable hepatitis C 51 FAMPYRA 51 varicella vaccine 51 recurrent ischemia 51 cryptogenic 51 perioperative mortality 51 clomipramine 51 LPV r 51 peak plasma concentrations 51 Asymptomatic 51 dosage regimens 51 neostigmine 51 iNO 50 lymphocytosis 50 serum creatinine 50 systolic BP 50 apnea hypopnea index 50 abciximab 50 artery stenosis 50 UA NSTEMI 50 hemoglobin A1c levels 50 urate lowering therapy 50 hypoglycemic episodes 50 postexposure 50 GI motility 50 interstitial pneumonia 50 clot busting drugs 50 Visual Analogue Scale VAS 50 invasive aspergillosis 50 leukocyte count 50 mitoxantrone 50 serum ALT 50 heavily pretreated 50 mCi 50 postoperative complication 50 chemoradiotherapy 50 HIV seroconversion 50 ml kg 50 depressive symptoms 50 bronchopulmonary dysplasia 50 aminotransferase levels 50 mesalamine granules 50 dosing interval 50 LEXIVA r 50 AGILECT R 50 pyridostigmine 50 varicella infection 50 rebleeding 50 NSTE ACS 50 interferon ribavirin 50 transaminase levels 50 receiving VICTRELIS 50 ULN 50 inflammatory lesions 50 plasma HCV RNA 50 mucosal healing 50 Ejection Fraction 50 weekly intravenous infusions 50 PaO 2 50 #mg doses [002] 50 chronic GVHD 50 pericardial effusion 50 COREG 50 myocardial infarction 50 HPA axis suppression 50 mechanical ventilation 50 cranial irradiation 50 neurologic outcomes 50 nonoperative treatment 50 pyrazinamide 50 undergoing bariatric surgery 50 leucopenia 50 nonfatal MI 50 salmeterol fluticasone 50 ancrod 50 antibiotic regimens 50 radical nephrectomy 50 anastomotic leak 50 HIV uninfected 50 corticosteroid therapy 50 Heavy menstrual bleeding 50 albuminuria 50 HbA 1c 50 oral glucose tolerance 50 abacavir lamivudine 50 CIMZIA TM 50 hypertensives 50 PREZISTA r 50 hepatic resection 50 leukoencephalopathy 50 oral corticosteroids 50 nadolol 50 folic acid supplement 50 MetS 50 anticoagulation therapy 50 DLTs 50 neurocognitive deficits 50 symptomatic hypotension 50 spontaneous preterm delivery 50 normothermic 50 #mmHg [001] 50 IBS symptoms 50 virologic response EVR 50 rFSH 50 anticholinergics 50 resolves spontaneously 50 cerebrovascular events 50 achieved sustained virological 50 tumor recurrence 50 membrane rupture 50 clot busting medicine 50 nebulization 50 PASI scores 50 mcg Albuferon 50 L. reuteri 50 lung resection 50 glucocorticoid therapy 50 salivary cortisol 50 XELOX 50 COPAXONE R 50 response CCyR 50 TEAEs 50 cytogenetic response 50 symptomatic VTE 50 mg q8h 50 MAS XR 50 asymptomatic carotid stenosis 50 tumor progression TTP 50 SGPT 50 HAART regimens 50 chemoradiation 50 onset 50 aneurysmal subarachnoid hemorrhage 50 pentoxifylline 50 IPAH 50 AZILECT 50 hydroxychloroquine 50 prostate cancer CaP 50 intraventricular hemorrhage 50 hsCRP levels 50 coinfected 50 chorioamnionitis 50 diagnostic angiography 50 Prophylaxis 50 genotypic resistance 50 dosing intervals 50 liver histology 50 lopinavir r arm 50 KOMBIGLYZE XR 50 hepatic metastases 50 ceftriaxone 50 MOTN awakenings 50 clodronate 50 fluvastatin 50 venous blood clots 50 serum urate 50 Thrombolysis 50 pheochromocytoma 50 ICD shocks 50 revaccination 50 pg ml 50 piperacillin tazobactam 50 cotrimoxazole 50 HBV vaccine 50 blood glucose concentrations 50 acute rheumatic fever 50 upper endoscopy 50 artery calcification 50 urine NGAL 50 ZOMIG Nasal Spray 50 nonvertebral fractures 50 LVEF 50 pg mL 50 calcium supplementation 50 bisphosphonate therapy 50 methotrexate 50 Hb levels 50 streptokinase 50 fasting triglyceride levels 50 euthyroid 50 QTc interval 50 anterior uveitis 50 RNA copies mL 50 serum phosphorus 50 rhTSH 50 symptomatic intracranial hemorrhage 50 â ‰ ¥ 50 exacerbations 50 radioiodine therapy 50 fondaparinux 50 glomerular filtration rate 50 intermittent claudication 50 VTEs 50 cerebral angiography 50 premenopause 50 polyp detection 50 antiretroviral regimen 50 NPH insulin 50 Isoniazid 50 maximal doses 50 status epilepticus 50 locoregional recurrence 50 C difficile infection 50 neurodevelopmental outcomes 50 T2DM 50 oral anticoagulation 50 screening colonoscopy 50 lung function 50 eplerenone 50 atrioventricular block 49 pyelonephritis 49 dosing cohorts 49 postoperative morbidity 49 intrapartum 49 steroid dexamethasone 49 antiviral prophylaxis 49 OSAHS 49 tumor histology 49 surgical debulking 49 estimated GFR 49 serum phosphate levels 49 lymph node dissection 49 APTIVUS 49 clopidogrel 49 FluCAM arm 49 corticosteroids 49 CC genotype 49 chronic periodontitis 49 #mg/m# [001] 49 ritonavir boosted 49 posaconazole 49 herpes zoster shingles 49 glycoprotein IIb IIIa inhibitors 49 variceal bleeding 49 Natalizumab 49 parasitemia 49 otamixaban 49 HBV infection 49 adrenal insufficiency 49 antiarrhythmic drugs 49 ALND 49 chronicity 49 co morbidities 49 depressive symptomatology 49 crossclamp 49 troponin T 49 clot busting 49 Adjuvant therapy 49 NIH CPSI 49 Subgroup analyzes 49 acute myocardial infarction AMI 49 systemic embolism 49 uncontrolled asthma 49 rt PA 49 renal flares 49 KRAS mutant tumors 49 ribavirin RBV 49 thyrotropin 49 weeks gestation 49 Score DAS# 49 intracranial hemorrhage ICH 49 #.#ng/ml 49 de ath 49 Acute renal failure 49 SRBD 49 visceral metastases 49 6MWD 49 postoperative AF 49 infarction STEMI 49 oxygen desaturation 49 mL/min/#.# m 2 49 STEMI 49 evaluable patients 49 ABC/3TC 49 subclinical hyperthyroidism 49 insulin glulisine 49 continuous intravenous infusion 49 symptomatic intracranial 49 zoster 49 spontaneous preterm birth 49 Thal Dex 49 ARIXTRA 49 Betaferon ® 49 plasma uric acid 49 urolithiasis 49 acromegalic patients 49 Index CDAI 49 neurologic progression 49 prednisone prednisolone 49 INVEGA ® 49 spirometric 49 corrected QT interval 49 RLAI 49 AST ALT 49 systolic hypertension 49 severe asthma exacerbations 49 lacunar 49 griseofulvin 49 metastatic lung cancer 49 ximelagatran 49 liver metastases 49 SNHL 49 PREZISTA ritonavir 49 coinfected patients 49 fluticasone salmeterol 49 % CI #.#-#.# [004] 49 tolvaptan 49 moderately emetogenic 49 betamethasone 49 paricalcitol 49 serum cortisol 49 colorectal adenoma 49 clinically meaningful improvement 49 chest radiographs 49 insulin glargine 49 rituximab monotherapy 49 hemodynamically stable 49 TDF FTC 49 RSV infection 49 % CI #.#-#.# [008] 49 onset atrial fibrillation 49 blastic phase 49 angiographically 49 glycemia 49 complete remissions 49 thrombolytics 49 nicardipine 49 MIRAPEX 49 pimecrolimus 49 nucleoside naive patients 49 CD4 counts 49 macroalbuminuria 49 lacosamide 49 APTIVUS ritonavir 49 leukemia AML 49 urinary albumin 49 trimethoprim sulfamethoxazole 49 cecal intubation 49 preoperatively 49 anti HBs 49 bolus injection 49 oral methylnaltrexone 49 intramuscular injections 49 infliximab therapy 49 eculizumab therapy 49 VIRAMUNE XR 49 SCIg 49 intracerebral haemorrhage 49 normotensive 49 colorectal liver metastases 49 gastric acidity 49 sequelae 49 hepatotoxicity 49 cytoreduction 49 atrophic gastritis 49 F FDG PET 49 adrenalectomy 49 Elitek 49 ischemic lesions 49 AGHD 49 cryptogenic stroke 49 Dose escalation 49 #mg/dl 49 subarachnoid hemorrhages 49 Perforomist Inhalation Solution 49 mg orally 49 TURBT 49 dysglycemia 49 severe hypoglycemia 49 eosinophilic pneumonia 49 CRp 49 extracolonic findings 49 daytime naps 49 nonobese 49 VIRAMUNE 49 neurosyphilis 49 atopic 49 underwent CABG 49 nadroparin 49 oral antidiabetic medication 49 mIU L 49 azoospermia 49 diabetes mellitus DM 49 corticosteroid dose 49 complete cytogenetic 49 BoNTA 49 antithrombotic therapy 49 REYATAZ ritonavir 49 lymphocyte counts 49 ng dL 49 Acute sinusitis 49 SHPT 49 nephrotoxic drugs 49 death reinfarction 49 AMOR IPAT 49 virologic suppression 49 FOLFOX4 49 KRAS status 49 ST elevation myocardial 49 renal allograft 49 activated partial thromboplastin 49 parathyroidectomy 49 aromatase inhibitor therapy 49 VP# [004] 49 nulliparous women 49 undetectable HBV DNA 49 corticosteroid dexamethasone 49 p = NS 49 RSV bronchiolitis 49 procalcitonin 49 UPPP 49 serum IGF 49 S aureus 49 anemia hemoglobin 49 stage IIIB 49 mIU mL 49 TMP SMX 49 interferon therapy 49 hypertensive patients 49 flexible sigmoidoscopy 49 vasospasm 49 Retreatment 49 interquartile range IQR 49 adjuvant therapy 49 malignant polyps 49 nelfinavir 49 dose regimen 49 gastric pH 49 umol L 49 macrovascular events 49 virologic 49 co trimoxazole 49 pulmonary dysfunction 49 calculated creatinine clearance 49 perimenopausal women 49 IOP lowering 49 elevated CRP 49 STN stimulation 49 juvenile idiopathic arthritis 49 daunorubicin 49 PPSV# 49 WNV infection 49 incontinence episodes 49 intracerebral hemorrhage 49 neutropenic patients 49 gestational age 49 efalizumab 49 trivalent inactivated influenza 49 debulking surgery 49 neoadjuvant treatment 49 serum potassium 49 initiating HAART 49 amenorrhoea 49 proliferative diabetic retinopathy 49 chemoradiation therapy 49 secondary efficacy endpoint 49 g dl 49 immunosuppression 49 drug eluting stent implantation 49 recurrent UTI 49 coronary calcification 49 bacteriuria 49 anticoagulant therapy 49 ESBLs 49 methotrexate therapy 49 ruboxistaurin 49 serologic testing 48 teriflunomide 48 dosed intravenously 48 primary percutaneous coronary 48 intravenous antibiotic 48 lipid lowering drugs 48 clot busting medication 48 carcinoid tumors 48 macrolide antibiotic 48 QRS interval 48 moderate renal impairment 48 untreated mice 48 nitrofurantoin 48 mild renal insufficiency 48 p = #.# [004] 48 CIN3 48 dosing cohort 48 CANCIDAS 48 respiratory symptoms 48 interferon beta therapy 48 neoadjuvant therapy 48 mmol l 48 elevated LDH 48 serum potassium levels 48 serum uric acid 48 Free Survival PFS 48 parasitaemia 48 esophagectomy 48 lung metastases 48 Renal dysfunction 48 univariate analysis 48 transaminases 48 serum calcium levels 48 myocardial infarction MI 48 antimuscarinic 48 sulfasalazine 48 abacavir 48 hyperglycaemia 48 iPTH 48 DMARDs 48 nephrotoxicity 48 β blocker 48 glucocorticoids 48 valacyclovir 48 GIST tumors 48 viral load 48 HBV DNA levels 48 Recurrences 48 anthracycline therapy 48 Stent thrombosis 48 IFN beta 48 pegIFN 48 undetectable viral loads